Source link : https://newshealth.biz/health-news/fda-approves-twice-yearly-shot-for-hiv-prevention/
(MedPage Today) — The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at-risk adults and adolescents, Gilead Sciences announced on Wednesday. An injectable HIV-1 capsid inhibitor… Source link : https://www.medpagetoday.com/hivaids/hivaids/116154 Author : Publish date : 2025-06-18 20:44:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Approves Twice-Yearly Shot for HIV Prevention first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-18 20:44:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8